VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
PHASE2
This study investigates the potential of vericiguat, a soluble guanylate cy...
The VERIFY Study: An Observational Study Called VERIFY to Learn More About the Use of Vericiguat in People With Chronic Heart Failure With Reduced Ejection Fraction
N/A
This is an observational study in which the health data of people with chro...
Status
Completed
Location
Bayer
Start Date
2023-07-11
Trial ID
NCT05974189
Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients
PHASE1
This study is intended to investigate the effect of nitroglycerin on verici...
A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without Food When Taken as a Single Dose in Liquid Form Suitable for Children Compared to a 10 Milligram (mg) Tablet That Releases the Active Substance Immediately
PHASE1
Researchers are looking for a better way to treat heart failure, a conditio...